PUBLIC COMPANY
save$MRNAModerna, Inc.
$MRNA174.38+176.97%Cambridge, MA, USupdated 3h ago
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
community read0 votes
pipeline
18
marketed
5
phase 3
1
catalysts ytd
2
approvals ytd
0
recalls ytd
0
Pipeline(18)
view full pipeline →pipeline depth18 products
5Phase 15Phase 21Phase 35Marketed2pre_registration
Marketed
Coronavirus Disease 2019 (COVID-19) KP.2 vaccine
Coronavirus Disease 2019 (COVID-19)
MarketedCoronavirus Disease 2019 (SARS-CoV-2) vaccine 2
Coronavirus Disease 2019 (COVID-19)
Marketeddavesomeran + elasomeran
Coronavirus Disease 2019 (COVID-19)
Marketedelasomeran
Coronavirus Disease 2019 (COVID-19)
MarketedmNEXSPIKE
Coronavirus Disease 2019 (COVID-19)
Phase 3mRNA-1403
Norovirus Infections
Phase 2intismeran autogene
Metastatic Melanoma
Phase 2mRNA-3705
Methylmalonic Acidemia
Phase 2mRNA-3927
Propionic Acidemia
Phase 2mRNA-4359
Solid Tumor
Phase 2respiratory syncytial virus vaccine
Respiratory Syncytial Virus (RSV) Infections
Fusion glycoprotein F0
Phase 1mRNA-1215
Nipah Virus (NiV) Infections
Upcoming
no upcoming catalysts on record
Recent(90d)
view all catalysts →Wall Street consensus
source: yahoo finance · 20 analystsmean target
$46.10
vs $49.56 now
implied upside
-7.0%
range: $21.00 – $135.00
consensus rating
Hold
2.96 / 5.0
rating distribution · 23 analysts
1
2
17
1
2
strong buystrong sell
recent actions (2)
- Apr 2, 26REITBarclays→ Equal-Weight
- Feb 23, 26REITPiper Sandler→ Overweight
Insider activity
source: SEC Form 4open-market buys + sells
routine RSU / option mechanics (6)
- Apr 2, 26tax coverMock James M · Chief Financial Officer703 sh
- Apr 2, 26option exerciseMock James M · Chief Financial Officer1,453 sh
- Apr 2, 26option exerciseMock James M · Chief Financial Officer1,453 sh
- Mar 5, 26tax coverMock James M · Chief Financial Officer5,704 sh
- Mar 5, 26tax coverKlinger Shannon Thyme · Chief Legal Officer5,704 sh
- Mar 5, 26option exerciseMock James M · Chief Financial Officer11,797 sh
🐶 Hiring Signal
Where Moderna, Inc. is staffing up — a leading indicator of pipeline and commercial priorities.
News
- Trump's FDA pick Overton good for psychedelics, new pain meds but bad for vaccines: analystsIf confirmed by the Senate, Heidi Overton—officially revealed Wednesday as President Donald Trump’s choice for FDA commissioner—is expected to be a boon for developers of psychedelic therapeutics a…biospace · 5h ago
- STAT+: Experts scrutinize Huidagene’s disclosures after patient deathMerck and Moderna's mRNA cancer vaccine, an expected nominee to lead the FDA, and more biotech news from The Readoutstat · 7h ago
- STAT+: Regeneron drug for disease that causes dangerous bone growth earns FDA approvalA Regeneron drug that treats an ultra-rare disease that causes bone to form where it's not meant to be has won approval.stat · 7h ago
- STAT+: American Cancer Society cancels alcohol industry fundraiserThe American Cancer Society had an optics problem: its annual Wine and Spirits Industry's Gala. It decided to do something about it.stat · 9h ago
- STAT+: Brain organoids, kept alive more than five years, matured like human brainsBrain organoids kept alive more than five years continued to develop and mature, and showed molecular and genetic signatures like those of human brains.stat · 9h ago
- Kolon TissueGene cuts 37 US staffers after Phase 3 failFollow along as BioSpace tracks job cuts and restructuring initiatives.biospace · 11h ago
- 11 companies hiring in New JerseyLooking for a biopharma job in New Jersey? Job postings in the area have increased year over year, according to BioSpace data. Here are 11 companies with open roles.biospace · 11h ago
- Moderna stock nearly doubles as Merck-partnered mRNA cancer vaccine meets Phase 3 goalMelanoma was slower to recur in patients receiving Merck and Moderna's mRNA vaccine with Keytruda, supporting use of the combination in adjuvant treatment. The partners plan to take the data to the…biospace · 11h ago
- STAT+: Pharmalittle: We’re reading about an FDA commish nominee, mRNA cancer vaccine results, and morePresident Trump is expected to nominate Heidi Overton, White House deputy director of domestic policy, to serve as the next FDA commissionerstat · 11h ago
- Dissecting Chinese trial strategy in wake of deathsCancer "vaccine" successfully slowed melanoma, dissecting Chinese trial strategy in wake of deaths, and more health news from Morning Roundsstat · 13h ago
Data sources
last refreshed 33m ago
Found something off?
comments(0)
5-min edit window · permanent after that